The need for higher bioavailability ingredients spurs innovation in the bone and joint health ingredients market, finds Frost & Sullivan’s recent analysis, Global Bone and Joint Health Ingredients Industry. The increasing geriatric population and the incidence of bone and joint health conditions are driving the global bone and joint health ingredients market. It will likely reach $6.01 billion by 2030 from $3.73 billion in 2021, an uptick at a compound annual growth rate (CAGR) of 5.4%. “Ingredient manufacturers’ focus on identifying...